Article Listing - Patient enrollment starts in Teva's Azilect study

NEUTOGENA ACQUIRES INTEREST IN CELLEGY

27 April 1992

Neutrogena Corp has acquired a minority interest in Cellegy Pharmaceuticals, a dermatological products R&D company. Full terms of the agreement...

CIBA-GEIGY CONFIDENT IN FORTHCOMING RESULTS

27 April 1992

Ciba-Geigy chairman Alex Krauer has expressed confidence in the company's forthcoming 1992 results. He adds that the company is actively...

PROMOTIONS AT MERCK & CO

27 April 1992

At world drug leader Merck & Co, Louis Sherwood has been named senior vice president of medical and scientific affairs....

CAPOTEN CUTS MORTALITY IN SAVE

27 April 1992

Bristol-Myers Squibb's angiotensin converting enzyme inhibitor product Capoten (captopril) reduces mortality by 17% in post-myocardial infarct patients without overt heart...

FRENCH VOLUNTARY AIDS TESTING MEASURES

27 April 1992

The French government has adopted four measures to encourage voluntary AIDS testing and will boost the state AIDS prevention budget...

EPHMRA MEETING

27 April 1992

The 31st European Pharmaceutical Market Research Association members conference will take place in Lyon, France, from June 3 to June...

GOOD SALES GROWTH FOR MAJOR US COS IN 1st QTR

27 April 1992

Good sales growth was experienced by the major US pharmaceutical companies announcing results for the first quarter of 1992 in...

CENTOXIN APPROVAL DELAYED AGAIN

27 April 1992

In a further blow to Centocor's prospects, the US Food and Drug Administration has again decided not to approve the...

ROBERTS TO MARKET J&J'S SUPPRELIN

27 April 1992

Roberts Pharmaceutical has ob-tained exclusive worldwide rights to Johnson & Johnson's newly-approved orphan drug Supprelin (histrelin) for the treatment of...

SB WINS QUEEN'S AWARD FOR BACTROBAN

27 April 1992

In the UK, SmithKline Beecham has won a 1992 Queen's award for technology for its topical antibiotic Bactroban (mupirocin), which...

Showing 94181-94190 of 95376 articles